Prostate-specific membrane antigen (PSMA) is a transmembrane glycoprotein that is
overexpressed in prostate cancer. Radiolabeled small molecules that bind with high affinity …

The aim of this review is to report on the current status of prostate-specific membrane
antigen (PSMA)-directed theranostics in prostate cancer (PC) patients. The value of 68 Ga …

Importance The presence of pelvic nodal metastases at radical prostatectomy is associated
with biochemical recurrence after prostatectomy. Objective To assess the accuracy of …

Importance In retrospective studies, 68 Ga-PSMA-11 positron emission tomographic (PET)
imaging improves detection of biochemically recurrent prostate cancer compared with …

Summary Background National Comprehensive Cancer Network guidelines consider 18 F-
fluciclovine PET-CT for prostate cancer biochemical recurrence localisation after radical …

Prostate-specific membrane antigen (PSMA)–ligand PET imaging provides unprecedented
accuracy for whole-body staging of prostate cancer. As PSMA-ligand PET/CT is increasingly …

Purpose: Systemic androgen-signaling inhibition added to ongoing androgen-deprivation
therapy (ADT) improved clinical outcomes in patients with nonmetastatic castration-resistant …

Target volume delineations for prostate cancer (PCa) salvage radiotherapy (SRT) after
radical prostatectomy are usually drawn in the absence of visibly recurrent disease. 68Ga …

The impact of prostate-specific membrane antigen (PSMA) PET/CT on management of
prostate cancer (PCa) patients with biochemical recurrence (BCR) is well established …

In this prospective survey of referring physicians, we investigated whether and how 68Ga-
labeled prostate-specific membrane antigen 11 (68Ga-PSMA-11) PET/CT affects the …